Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.
about
Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalisMechanisms of action of 5-fluorocytosineEpidemiology of invasive candidiasis: a persistent public health problemThe ins and outs of DNA fingerprinting the infectious fungiA Candida albicans dispersed, repeated gene family and its epidemiologic applications.Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.Complementation analysis of resistance to 5-fluorocytosine in Candida albicansAntifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.High-frequency switching in Candida albicans.Flucytosine resistance is restricted to a single genetic clade of Candida albicans.Antifungal drug resistance.Drug resistance in human pathogenic fungi.Activity of phenothiazines against medically important yeasts.Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoSusceptibility testing of fungi: current status of the standardization process.An update on antifungal targets and mechanisms of resistance in Candida albicans.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Candida albicans serotype analysis by flow cytometry.Rapid susceptibility testing of fungi by flow cytometry using vital staining.Application of DNA typing methods to epidemiology and taxonomy of Candida speciesResults of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin BMicrotiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.Comparison between methods for serotyping of Candida albicans produces discrepancies in resultsAnalysis of Candida albicans phenotypes from different geographical and anatomical sources.Antifungals to treat Candida albicans.Candidiasis.The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans.Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.Serotype prevalence of Candida albicans from blood culture isolates.Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.Antifungal susceptibility testingInhibition and killing of Candida albicans in vitro by five imidazoles in clinical use.Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.Subgingival strains of Candida albicans in relation to geographical origin and occurrence of periodontal pathogenic bacteria.Drug resistance in Candida albicans and Candida glabrata.
P2860
Q28360623-B5964500-F66C-4B2C-8ED6-B1A1D5671D74Q28366384-F9806740-0254-44B0-9366-DEB4A153A10FQ29616758-510510D2-4F4A-4D49-BAE8-BA032EF19646Q33555593-A65A7FB4-AEC1-4515-BE07-692AFDF72844Q33556333-B2B14D25-6CEC-44B1-99CA-1C36FD9DEC2DQ33684486-1C5467B1-7FF6-4BD6-8CD5-938C3559773CQ33738111-777BCEA7-13D5-40DC-868A-2CE8B0F130BBQ33749111-8D1582F0-6BAE-4989-ADE1-8B1CB942C549Q34142406-8FF81108-C4EA-4AAA-A0FC-B20606DE9368Q34402581-D537AC54-08E3-4F22-A8BD-E8C334F79B8FQ35007285-FEDF3FA3-4132-4DFA-AE56-5A3FC36A0157Q35040008-E7F7D092-E815-4897-91F9-E66C31ED4F18Q35376744-E353CC2A-B3F7-44D7-AD0C-D2CF2A020D6EQ35540629-F217CBEF-A1B9-436E-AD82-D9FEE27ACEF4Q35640149-81EDAB60-18CD-4CFE-8178-99977980787FQ35652874-5D1892A8-6932-44D7-9F81-613F2EFB38AFQ35903839-742E2C73-1654-47CC-A558-EBA839E5C354Q36235037-2D7B3F65-B540-459E-8D5C-6753953F9985Q36528018-53D2F660-0B71-4835-BC2A-8A27E13CA9DEQ36537515-D75D099B-4ED7-43D8-A72D-0874A1237930Q36542368-1E7EF65C-0D2A-45EA-ACB3-6C5A641225A8Q37139692-FD23D069-C58B-43BD-A863-5F71461D4384Q37202190-5289EB22-3AD9-433C-B63B-EC8C1DA9A3B0Q37210734-BA37D5A4-E9CD-4691-B77B-8F5EE2E47658Q37234720-FF310AA2-7C88-421D-8003-86E33CF1BDBBQ37258061-13279112-55B8-4C9C-BF11-D4524DE10E1BQ37763928-74ACF3A2-8F0F-4D1C-90F7-3FF3D1156118Q38229535-9FEED3D9-B8E2-49ED-BC34-D8970A1E14FCQ39685110-B5E32AB8-2B2C-4D55-87B1-10C92B17C3DDQ39833505-AE45F4F0-1429-4520-A286-1EAE1CD0C86EQ39881200-58FFD034-13F3-48F2-AFCE-03E727165F44Q40185025-AE0BAEB0-04E1-4ED1-9DDD-2DBDAF55749DQ40206965-92CD09D2-ADA7-4143-A041-389CC27EFEFDQ40795131-F24D40AE-1790-4901-97B5-2D02E43BA41DQ42929831-09D7C133-81D9-4A4B-8903-72683F01F05EQ43664192-3D305358-FF78-4719-AE22-DE3A410D675CQ44142582-74416821-025C-4E05-A358-F3062A05BAB0Q54394043-E03E139E-1520-4C6A-8614-348036694AF6
P2860
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Susceptibility to 5-fluorocyto ...... olates from the United States.
@ast
Susceptibility to 5-fluorocyto ...... olates from the United States.
@en
type
label
Susceptibility to 5-fluorocyto ...... olates from the United States.
@ast
Susceptibility to 5-fluorocyto ...... olates from the United States.
@en
prefLabel
Susceptibility to 5-fluorocyto ...... olates from the United States.
@ast
Susceptibility to 5-fluorocyto ...... olates from the United States.
@en
P2093
P2860
P356
P1476
Susceptibility to 5-fluorocyto ...... olates from the United States.
@en
P2093
P2860
P304
P356
10.1128/AAC.22.3.482
P407
P577
1982-09-01T00:00:00Z